Skip to main content
. Author manuscript; available in PMC: 2022 Jan 20.
Published in final edited form as: Int J Cancer. 2020 Jul 16;147(11):3160–3167. doi: 10.1002/ijc.33119

FIGURE 1.

FIGURE 1

Mean (SD) of pretherapeutic and posttherapeutic QTcf interval among different TKIs. Significant differences were found in comparisons between pre-QTcf vs post-QTcf values for dasatinib (P value = .001), imatinib (P value = .001), nilotinib (P value = .001), sunitinib (P value = .001) and pazopanib (P value < .001)